Clinical trials
Completed beta-Thalassemia trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 26 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celgene | 4 |
| Novartis Pharmaceuticals | 3 |
| Consorzio per Valutazioni Biologiche e Farmacologiche | 2 |
| Ente Ospedaliero Ospedali Galliera | 2 |
| Genetix Biotherapeutics Inc. | 2 |
| Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 1 |
| ApoPharma | 1 |
| Azienda Ospedaliera V. Cervello | 1 |
| Cerus Corporation | 1 |
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| beta-Thalassemia | 26 |
| Thalassemia | 8 |
| Iron Overload | 4 |
| Anemia, Sickle Cell | 2 |
| Genetic Diseases, Inborn | 2 |
| Hematologic Diseases | 2 |
| Hemoglobinopathies | 2 |
| alpha-Thalassemia | 2 |
| Anemia | 1 |
| Anemia, Hemolytic | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.